Analyst Ratings for Eagle Pharmaceuticals Inc. (EGRX)Updated: 2017-07-28
An average rating of Overweight has been given to Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) by analysts covering the stock. EGRX had previously received a consensus rating of Overweight a month ago.
A buy rating was issued by 3 analysts, 0 gave an overweight rating, 0 issued a hold rating, 1 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.
Several price targets were given for EGRX by the analysts covering the stock. The highest price target was 118, implying potential capital gains of 132.47 percent. The minimum price target given was 57, implying potential capital losses of 12.29 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.
In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. The average change in earnings estimates over the last 90 days is -23.85 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -6.27 percent.
People are often interested in whether analysts were united in the direction of their revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 0 analysts decreased their estimates.
EGRX has an estimated earnings growth rate of -46.64 percent as forecasted by analysts. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. Investors like to see smaller values for the PEG ratio, because that is often interpreted as the company being fairly priced relative to its growth rate. Many investors consider PEG ratios between 0 and 1 as preferrable, although it is frequently more appropriate to compare PEG ratios to the company's peers. EGRX has a PEG ratio of -0.17.
In the trailing 52-weeks, EGRX hit 97.15 at the highest peak, while it's lowest trading point was 42.33. Today's price is 19.91 percent above the 52-week low, and below the high by 47.75 percent. EGRX has a price/earnings ratio of 7.87. Investors typically compare the P/E ratio to a company's peers in the industry. The EGRX value stock report compares EGRX to some of its peers using value stock charts. The market cap of EGRX is $0.80613 billion. EGRX is estimated to release their earnings results for the quarter on 0000-00-00, days from today.